Zinc deficiency and supplementation in autism spectrum disorder and Phelan‐McDermid syndrome
Approximately 1 in 36 children are diagnosed with autism spectrum disorder (ASD). The disorder is four times more common in males than in females. Zinc deficiency and mutations in
SHANK2
and
SHANK3
(members of a family of excitatory postsynaptic scaffolding proteins) are all risk factors that may contribute to the pathophysiology of the disease. The presence of shankopathies (loss of one copy of the
SHANK3
gene) can lead to the development of Phelan‐McDermid syndrome (PMDS)—a rare genetic disorder characterized by developmental delay, intellectual disability, poor motor tone, and ASD‐like symptoms. We reviewed the relationship between zinc, ASD, and PMDS as well as the effect of zinc supplementation in improving symptoms of ASD and PMDS based on 22 studies published within 6 years (2015–2020). Zinc deficiency (assessed by either dietary intake, blood, hair, or tooth matrix) was shown to be highly prevalent in ASD and PMDS patients as well as in preclinical models of ASD and PMDS. Zinc supplements improved the behavioral deficits in animal models of ASD and PMDS. Clinical trials are still needed to validate the beneficial therapeutic effects of zinc supplements in ASD and PMDS patients.
No keywords indexed for this article. Browse by subject →
Thomas Bourgeron
Andreas M. Grabrucker, Michael J. Schmeisser, Michael Schoen et al.
Claire S. Leblond, Caroline Nava, Anne Polge et al.
Xiao Liu, Juan Liu, Xueqin Xiong et al.
Showing 50 of 80 references
M.V. Conti, S. Santero · 2023
- Published
- Feb 03, 2022
- Vol/Issue
- 100(4)
- Pages
- 970-978
- License
- View
You May Also Like
Marina D. Kirkitadze, Gal Bitan · 2002
504 citations
J. B. Fishman, J. B. Rubin · 1987
437 citations
Vittorio Colangelo, Jill Schurr · 2002
433 citations
A. Nishiyama, X.-H. Lin · 1996
420 citations
Siddharama Pawate, Qin Shen · 2004
384 citations